| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/29/2010 | CN101928279A 3-amino-2-pyrones cyclooxygenase inhibitors as well as preparation method and application thereof |
| 12/29/2010 | CN101928262A Biologically active methylene blue derivatives |
| 12/29/2010 | CN101928259A 2-arylthiazole derivative and medicament composition thereof |
| 12/29/2010 | CN101928136A Method for preparing fluoridated hydroxyapatite and application thereof |
| 12/29/2010 | CN101926982A Medicament or health-care food for increasing bone mineral density |
| 12/29/2010 | CN101926978A Medicine composition for promoting bone and bony articulation health |
| 12/29/2010 | CN101926969A Traditional Chinese medicine composition for treatment of cervical spondylopathy and preparation method thereof |
| 12/29/2010 | CN101926957A Medicinal composition for treating arthralgia syndrome and preparation method thereof |
| 12/29/2010 | CN101926939A Chinese medicinal preparation for treating rheumatic diseases |
| 12/29/2010 | CN101926937A Quality control method of granules with functions of relaxing muscles and tendons and removing obstruction from meridians |
| 12/29/2010 | CN101926926A Traditional Chinese medicinal preparation for treating rheumatic arthritis and chronic infectious arthritis |
| 12/29/2010 | CN101926920A Traditional Chinese medicine composition for treatment of rheumatoid arthritis and preparation method thereof |
| 12/29/2010 | CN101926906A Chinese medicinal composition for treating early and medium femoral necrosis |
| 12/29/2010 | CN101926905A Application of Chinese medicinal composition containing components for invigorating spleen and reducing phlegm in preparing medicine for treating early and medium stage femoral head necrosis |
| 12/29/2010 | CN101926904A Medicinal liquor for treating rheumatic arthralgia and osteoarthrosis |
| 12/29/2010 | CN101926896A Traditional Chinese medicinal preparation for treating gout and preparation method thereof |
| 12/29/2010 | CN101926888A Externally-applied medicament for treating gout |
| 12/29/2010 | CN101926878A Chinese medicinal composition for treating osteoarthritis and preparation method thereof |
| 12/29/2010 | CN101926867A Bone fracture recovering soup |
| 12/29/2010 | CN101926866A Anti-hyperosteogeny plaster |
| 12/29/2010 | CN101926863A Method for identifying Nigella glandulifera Freyn medicinal material |
| 12/29/2010 | CN101926860A Peony extract-methotrexate composition, preparation method thereof and use thereof |
| 12/29/2010 | CN101926855A Medicinal tea for reducing uric acid of patient with gout |
| 12/29/2010 | CN101926837A Preparation method of kalopanax septemlobus leaf total effective part and medical application thereof |
| 12/29/2010 | CN101926815A Paeoniflorin and glycyrrhetinic acid composition and preparation method and application thereof |
| 12/29/2010 | CN101926814A Use of cycloartane compounds for treating arthritis |
| 12/29/2010 | CN101926808A Glucosamine formulations |
| 12/29/2010 | CN101926803A Application of quinazoline compounds |
| 12/29/2010 | CN101926802A Application of quinazoline compounds |
| 12/29/2010 | CN101926795A Medicinal composition for treating hyperur icemia |
| 12/29/2010 | CN101926794A Medicinal composition for treating gout |
| 12/29/2010 | CN101926778A Pamidronate disodium freeze-dried powder injection and preparation method thereof |
| 12/29/2010 | CN101618030B Triptolide transdermal patch and preparation method thereof |
| 12/29/2010 | CN101445504B Dioxane-2-alkyl carbamates derivatives |
| 12/29/2010 | CN101444523B Application of pueraria flower glucoside in preparation of medical compound for remedying osteoporosis |
| 12/29/2010 | CN101366887B Externally washing traditional Chinese medicine preparation for detumescence and dissipation blood stasis |
| 12/29/2010 | CN101322794B Medicine for treating cervical spondylosis, ANFH and Lumbar Disc Herniation |
| 12/29/2010 | CN101317958B Medicament for treating uarthritis, that is Tongfengning capsule and preparation method thereof |
| 12/29/2010 | CN101309918B [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases |
| 12/29/2010 | CN101244181B Plaster for bone paralysis with function of qufengshengshi, blood circulation activating and stasis removing, and removing the obstruction in the channels to relieve pain, and preparation thereof |
| 12/29/2010 | CN101214254B New use of mangiferin compounds |
| 12/29/2010 | CN101209288B Corydalis decumbentis orally disintegrating tablets |
| 12/29/2010 | CN101054412B Pathogenic gene for far end arthrosis bend, detection method and application thereof |
| 12/29/2010 | CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
| 12/29/2010 | CA2781865A1 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases |
| 12/29/2010 | CA2765985A1 5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors |
| 12/29/2010 | CA2764963A1 Method for treating a patient at risk for developing an nsaid-associated ulcer |
| 12/28/2010 | USRE42014 Pharmaceutical compositions |
| 12/28/2010 | US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them |
| 12/28/2010 | US7858789 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines |
| 12/28/2010 | US7858786 Pyrimidines and pyrazines useful as modulators of ion channels |
| 12/28/2010 | US7858785 1-(2-{5-Chloro-4-[5-(4-fluoro-phenylimino)-4-methyl-4,5-dihydro-[1,3,4]thiadiazol-2-yl]-pyrimidin-2-ylamino}-ethyl)-5,5-dimethyl-imidazolidine, useful for treating diseases mediated by polo-like kinase 1, such as rheumatoid arthritis and breast cancer; antiproliferative agents |
| 12/28/2010 | US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2 |
| 12/28/2010 | US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 12/28/2010 | US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 12/23/2010 | WO2010148234A1 Sap variants and their use |
| 12/23/2010 | WO2010147677A2 Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone |
| 12/23/2010 | WO2010147547A1 Novel peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation |
| 12/23/2010 | WO2010147109A1 Angiogenesis inducer comprising genetically modified gelatin and basic fibroblast growth factor |
| 12/23/2010 | WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof |
| 12/23/2010 | WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor |
| 12/23/2010 | WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators |
| 12/23/2010 | WO2010146236A1 Urea substituted sulphonamide derivatives |
| 12/23/2010 | WO2010145903A1 New therapeutical uses of inecalcitol |
| 12/23/2010 | WO2010145207A1 Liquiritigenin derivatives, preparation methods and uses thereof |
| 12/23/2010 | WO2010145192A1 Mangiferin-berberine salt, manufacturing method and use thereof |
| 12/23/2010 | WO2010107225A3 Pharmaceutical composition for preventing and treating arthritis, containing sulforaphane as an effective ingredient |
| 12/23/2010 | WO2010104577A3 Methods and kits for treating joints and soft tissues |
| 12/23/2010 | WO2010067339A3 Fusion protein capable of binding vegf-a and tnf-alpha |
| 12/23/2010 | US20100324564 Particles, grains or granules for the treatment of an injured vertebra |
| 12/23/2010 | US20100324500 Bone-Replacement Materials, Methods and Devices |
| 12/23/2010 | US20100324146 Dendrimeric Enzyme Inhibitors |
| 12/23/2010 | US20100324108 Substituted isoindoline-1,3-dione derivatives |
| 12/23/2010 | US20100324104 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 12/23/2010 | US20100324093 Ccr9 inhibitors and methods of use thereof |
| 12/23/2010 | US20100324089 Anti-inflammatory composition |
| 12/23/2010 | US20100324084 Urea derivatives of tropane, their preparation and their therapeutic application |
| 12/23/2010 | US20100324082 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS |
| 12/23/2010 | US20100324073 Pyrazolo [1,5-A] Pyrimidine Compounds |
| 12/23/2010 | US20100324071 Novel glucokinase activators and methods of using same |
| 12/23/2010 | US20100324050 Inhibitors of bruton's tyrosine kinase |
| 12/23/2010 | US20100324026 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha |
| 12/23/2010 | US20100324001 Novel Methods for the Treatment of Inflammatory Diseases |
| 12/23/2010 | US20100323999 Therapeutic Molecules and Methods-1 |
| 12/23/2010 | US20100323997 Novel uses |
| 12/23/2010 | US20100323994 Substituted imidazopyridazines useful as kinase inhibitors |
| 12/23/2010 | US20100323990 Ship 1 modulator prodrugs |
| 12/23/2010 | US20100323987 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 12/23/2010 | US20100323981 Treatment of statin side effects |
| 12/23/2010 | US20100323974 Inhibitors of PARP Activity and Uses Thereof |
| 12/23/2010 | US20100323969 Compounds Binding to P-Selectin |
| 12/23/2010 | US20100323968 Process of inhibiting cell death in injured cartilage |
| 12/23/2010 | US20100323964 New non-selective somatostatin analogues |
| 12/23/2010 | US20100323956 Glucose-regulating polypeptides and methods of making and using same |
| 12/23/2010 | US20100323038 Pharmaceutical Compositions |
| 12/23/2010 | US20100323026 Sustained release preparation for tissue regeneration therapy |
| 12/23/2010 | US20100322994 Particulate cartilage system |
| 12/23/2010 | US20100322993 Injectable biocompatible composition |
| 12/23/2010 | US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same |
| 12/23/2010 | US20100322921 METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR Va ANTIBODIES AND USE THEREOF |